|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 555 WEST 57TH STREET |
Address2 |
|
City | NEW YORK |
State | NY |
Zip Code | 10019 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 16830-12
|
||||||||
|
6. House ID# 324950000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: David Rich |
Date | 7/19/2018 10:56:35 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller-Johnson bill, and the Trump Administration's FY 2019 budget proposal.
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system.
Discussions with HHS and DHS regarding cybersecurity issues.
Advocated for individual marketplace stabilization measures, including the funding of ACA cost sharing reduction payments in standalone legislation and in FY 2018 funding legislation.
Advocated on graduate medical education measures, Medicaid reimbursement issues, and privacy and regulatory measures in the SUPPORT for Patients and Communities Act (support) (H.R. 6)
Support legislation to align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA), The Overdose Prevention and Patient Safety Act (support) (H.R. 6082), and support the legislations inclusion in the SUPPORT for Patients and Communities Act (support) (H.R. 6)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, Food & Drug Administration (FDA), Substance Abuse & Mental Health Services Administration (SAMHSA), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Susan |
Waltman |
|
|
|
Elisabeth |
Wynn |
|
|
|
Laura |
Alfredo |
|
|
|
Karen |
Heller |
|
|
|
Kathleen |
Shure |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal.
Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose).
Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose).
Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool.
Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal.
Provide comments to CMS addressing payments to off-campus hospital outpatient departments.
Support legislation to reverse the cuts to the 340B Drug Discount Program in CMS Final 2017 OPPS Rule, the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support)
Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes.
Oppose legislation that would harm Medicaid GME programs including the Medicaid Graduate Medical Education Transparency Act (oppose)
Support legislation that would repeal the IMD exclusion (support) (H.R. 5797), and support the legislations inclusion in the SUPPORT for Patients and Communities Act (support) (H.R. 6)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Karen |
Heller |
|
|
|
Elisabeth |
Wynn |
|
|
|
Timothy |
Johnson |
|
|
|
Kathleen |
Shure |
|
|
|
Aisling |
Zaccarelli |
|
|
|
Lee |
Perlman |
|
|
|
Laura |
Alfredo |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline shortages.
Oppose legislation that would harm the 340B Drug Discount Program for safety net hospitals and support legislation to prevents the implementation of the cuts in CMS Final 2017 OPPS Rule (CMS-2017-0091), the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support)
Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars.
Raise awareness about injectable opioid shortages, urge engagement by the Food & Drug Administration Office of Drug Shortages and approval by the Drug Enforcement Agency of CII quota requests to increase production of injectable opioid products in short supply.
Submitted comments to DEA urging the revision of its quota allocation process to recognize the unique institutional needs for injectable opioids.
Supported legislation to increase competition in the drug marketplace, the CREATES Act (S. 974) (support)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
Lee |
Perlman |
|
|
|
Aisling |
Zaccarelli |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal.
Oppose President Trumps FY 19 budget proposal (Efficient, Effective, Accountable: An American Budget), and it funding cuts and reforms to Federal GME programs, Medicaid uncompensated care pools, hospital outpatient departments, bad debt payments, and other hospital related provisions.
The Bipartisan Budget Act of 2018 (H.R. 1892) (support) and specific hospital related provisions in the legislation, including increased funding for the National Institutes of Health (NIH) (support), disaster relief funding and increased Medicaid funding for Puerto Rico and the US Virgin Islands (support), and the inclusion of the cut to Medicare payments for hospitals that discharge patients to hospice care (oppose).
Oppose House Republicans FY 2019 budget proposal (A Brighter American Future), and its funding cuts and reforms to Medicaid and Medicare, proposed reforms to federal GME programs, and efforts to repeal the Affordable Care Act (ACA). Support for provisions related to medical malpractice reform.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals.
Provided comments regarding the suspension of the H1-B visa Premium Processing program.
Acted as a fact witness and amicus in legal challenges to the Trump Administrations executive order (Protecting the Nation for Foreign Terrorists Entry into the United States)
17. House(s) of Congress and Federal agencies Check if None
White House Office, Homeland Security - Dept of (DHS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Laura |
Alfredo |
|
|
|
Tim |
Johnson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
The Childrens Health Insurance Program, including the reauthorization of the program in the January 2018 continuing resolution to fund the Federal government (support) (H.R. 195) and the extension of the program in the Bipartisan Budget Act of 2018 (support) (H.R. 1892).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Discussed post-hurricane disaster response by the group purchasing industry, and related efforts to bring needed supplies and drugs to providers in Puerto Rico.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lee |
Perlman |
|
|
|
Aisling |
Zaccarelli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: www.gnyhaventures.com
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
GNYHA Ventures, Inc. |
|
|
||||||||||||
GNYHA Management Corporation |
|
|
||||||||||||
Acurity, Inc. |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |